MetaCap

Wave Life Sciences Insider Trades

NASDAQ: WVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.46-0.01 (-0.29%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $27.93M
Sales
0 · $0
Shares bought / sold
1.47M / 0
Net activity
Net buying $27.9 million

Wave Life Sciences insider activity

Over the last 12 months, Wave Life Sciences insiders reported 9 transactions on SEC Form 4: 1 open-market purchase and 0 sales. Insiders bought $27.9 million and sold $0 worth of stock, for net insider buying of $27.9 million. The most recent filing shows Verdine Gregory L. (Director) reporting a transaction in 10,700 shares on Oct 5, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put WVE's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

WVE insider transactions

Wave Life Sciences insider transactions
DateInsiderTypeSharesValueFiling
Oct 5, 2026Wagner Heidi LDirectorAward10,700—Form 4
Oct 5, 2026Rawcliffe AdrianDirectorAward10,700—Form 4
Oct 5, 2026CORRIGAN MARKDirectorAward10,700—Form 4
Oct 5, 2026HENRY CHRISTIAN ODirectorAward10,700—Form 4
Oct 5, 2026TAKANASHI KENDirectorAward10,700—Form 4
Oct 5, 2026Tan Aik NaDirectorAward10,700—Form 4
Oct 5, 2026RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & Kolchinsky Peter & Shah Rajeev M.DirectorAward10,700—Form 4
Oct 5, 2026Verdine Gregory L.DirectorAward10,700—Form 4
Dec 11, 2025GSK plc10% OwnerBuy1,470,000$27.93MForm 4
Sep 27, 2024GSK plc10% OwnerBuy2,791,930$22.34MForm 4
Dec 7, 2023GSK plc10% OwnerBuy3,300,000$16.50MForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related